Systemic therapy for bladder cancer – a medical oncologist’s perspective
Open Access
- 13 February 2014
- journal article
- Published by Sciedu Press in Journal of Solid Tumors
- Vol. 4 (2) , 25-35
Abstract
Systemic therapy for bladder cancer – a medical oncologist’s perspectiveKeywords
This publication has 72 references indexed in Scilit:
- Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II studyAsia-Pacific Journal of Clinical Oncology, 2012
- Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder CancerMediators of Inflammation, 2012
- Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987Journal of Clinical Oncology, 2012
- Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial CancerJournal of Cancer, 2012
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 TrialJournal of Clinical Oncology, 2011
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06Journal of Clinical Oncology, 2009
- A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)Journal of Urology, 2009
- Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the BladderJournal of Urology, 2008
- Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802)Cancer, 2008
- Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursEuropean Journal of Cancer, 2006